DV
Dividend Vision

GLMD — Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd (GLMD)

Total return is -100.0% over the past 12.4 years, 517.5 points behind SPY at 417.5%. Its deepest 1-year drawdown was 70.9%.

This is a single-stock equity holding in Galmed Pharmaceuticals Ltd, a pharmaceutical company, rather than a diversified ETF. The holding does not currently pay distributions and lacks publicly available information on expense ratio and assets under management. This equity position appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those pursuing dividend income or broad market diversification.

GLMD key facts

Asset type
Stock
Asset class
Equity
Inception date
03/13/2014
Last close
$0.52
Market cap
$4,194,736
Average volume
43200.0
Beta
0.743
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.06